The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.

作者: Elena Novakova , Maria Stefkovicova , Maria Garabasova Kopilec , Martin Novak , Nina Kotlebova

DOI: 10.1016/J.IJID.2019.10.038

关键词:

摘要: Abstract Aim To obtain standardized epidemiological data for Clostridium difficile infection (CDI) in Slovakia. Methods Between October and December 2016, 36 hospitals Slovakia used the European Centre Disease Prevention Control (ECDC) surveillance protocol. Results The overall mean CDI incidence density was 2.8 (95% confidence interval 1.9–3.9) cases per 10 000 patient-days. Of 332 cases, 273 (84.9%) were healthcare-associated, 45 (15.1%) community-associated, 14 (4.2%) of recurrent CDI. A complicated course reported 14.8% (n = 51). outcome available 95.5% (n = 317). 35 patients (11.1%) who died, 34 did so within 30 days after their diagnosis. 78 isolates obtained from 12 hospitals, 46 belonged to PCR ribotype 001 (59.0%; 11 hospitals) 23 176 (29.5%; six hospitals). total 73 (93.6%) showed reduced susceptibility moxifloxacin (ribotypes 176; p  Conclusions These results show emergence C. ribotypes 027 with a predominance 2016. Given that an almost homogeneous detected isolates, this stresses importance reducing fluoroquinolone prescriptions Slovak healthcare settings.

参考文章(32)
O. Nyc, M. Krutova, A. Liskova, J. Matejkova, J. Drabek, E. J. Kuijper, The emergence of Clostridium difficile PCR-ribotype 001 in Slovakia European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 34, pp. 1701- 1708 ,(2015) , 10.1007/S10096-015-2407-9
L Alcalá, A Martín, M Marín, M Sánchez-Somolinos, P Catalán, T Peláez, Emilio Bouza, Spanish Clostridium difficile Study Group, None, The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clinical Microbiology and Infection. ,vol. 18, ,(2012) , 10.1111/J.1469-0691.2012.03883.X
Cornelis W. Knetsch, Elisabeth M. Terveer, Chris Lauber, Alexander E. Gorbalenya, Céline Harmanus, Ed J. Kuijper, Jeroen Corver, Hans C. van Leeuwen, Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages Infection, Genetics and Evolution. ,vol. 12, pp. 1577- 1585 ,(2012) , 10.1016/J.MEEGID.2012.06.003
Kerrie A Davies, Christopher M Longshaw, Georgina L Davis, Emilio Bouza, Frédéric Barbut, Zsuzsanna Barna, Michel Delmée, Fidelma Fitzpatrick, Kate Ivanova, Ed Kuijper, Ioana S Macovei, Silja Mentula, Paola Mastrantonio, Lutz von Müller, Mónica Oleastro, Efthymia Petinaki, Hanna Pituch, Torbjörn Norén, Elena Nováková, Otakar Nyč, Maja Rupnik, Daniela Schmid, Mark H Wilcox, Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID) The Lancet Infectious Diseases. ,vol. 14, pp. 1208- 1219 ,(2014) , 10.1016/S1473-3099(14)70991-0
T. Pelaez, E. Cercenado, L. Alcala, M. Marin, A. Martin-Lopez, J. Martinez-Alarcon, P. Catalan, M. Sanchez-Somolinos, E. Bouza, Metronidazole Resistance in Clostridium difficile Is Heterogeneous Journal of Clinical Microbiology. ,vol. 46, pp. 3028- 3032 ,(2008) , 10.1128/JCM.00524-08
Warren N. Fawley, C. W. Knetsch, Duncan R. MacCannell, Celine Harmanus, Tim Du, Michael R. Mulvey, Ashley Paulick, Lydia Anderson, E. J. Kuijper, Mark H. Wilcox, Development and Validation of an Internationally-Standardized, High-Resolution Capillary Gel-Based Electrophoresis PCR-Ribotyping Protocol for Clostridium difficile PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0118150
Martijn P Bauer, Daan W Notermans, Birgit HB van Benthem, Jon S Brazier, Mark H Wilcox, Maja Rupnik, Dominique L Monnet, Jaap T van Dissel, Ed J Kuijper, Clostridium difficile infection in Europe: a hospital-based survey The Lancet. ,vol. 377, pp. 63- 73 ,(2011) , 10.1016/S0140-6736(10)61266-4